Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Charite - Universitatsmedizin Berlin has 1 pending office action in Biotechnology & Pharmaceuticals. The profile identifies 1 distinct examiner and 1 distinct art unit, placing the matter within a single examination path. Counsel can direct its review to the scientific claims, the examiner’s objections, and the specification support for the asserted technical distinctions.
ABEYRATNE-PERERA, HASHANTHI KOMITIGE is the busiest examiner, with 1 pending matter. The profile shows no additional examiner or art-unit assignment. A targeted response to the single open file can address the prosecution issues while preserving the supported scope of the biotechnology or pharmaceutical claims.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ABEYRATNE-PERERA, HASHANTHI KOMITIGE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18760115 | NEUROPEPTIDE-EXPRESSING VECTORS AND METHODS FOR THE TREATMENT OF EPILEPSY | ABEYRATNE-PERERA, HASHANTHI KOMITIGE | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18760115 | NEUROPEPTIDE-EXPRESSING VECTORS AND METHODS FOR THE TREATMENT OF EPILEPSY | ABEYRATNE-PERERA, HASHANTHI KOMITIGE | 1632 | §102§103§112 | Non-Final OA | — | Pending | Jul 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCharite - Universitatsmedizin Berlin has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Hashanthi Komitige Abeyratne-Perera has the most, with 1 of Charite - Universitatsmedizin Berlin's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.